Non-Adherence to Disease-Modifying Anti-Rheumatic Drugs in Patients with Rheumatoid Arthritis: An Italian Survey

被引：0
|
作者：
Bianchi, Gerolamo [1 ]
Carletto, Antonio [2 ]
Epis, Oscar M. [3 ]
Scioscia, Crescenzio [4 ]
Semeraro, Angelo [5 ]
Donati, Chiara [6 ]
Bazzichi, Laura [7 ]
Lapadula, Giovanni [8 ]
Sinigaglia, Luigi [9 ]
Lo Monaco, Andrea [10 ]
机构：
[1] Osped La Colletta, Div Reumatol, Genoa, Italy
[2] Univ Verona, Rheumatol Unit, I-37100 Verona, Italy
[3] AO Osped Niguarda Ca Granda, Rheumatol Unit, Milan, Italy
[4] Univ Bari Aldo Moro, DIM Sez Reuamtol, Bari, Italy
[5] ASL Taranto, Unita Operat Reumatol, Taranto, Italy
[6] Roche SpA, Monza, Italy
[7] Univ Pisa, Div Reumatol, Pisa, Italy
[8] Univ Bari, DIMIMP Rheumatol Unit, Bari, Italy
[9] IOG Pini, Rheumatol Dept, Milan, Italy
[10] Osped S Anna Ferrara, Ferrara, Italy
来源：
ARTHRITIS & RHEUMATOLOGY | 2015年 / 67卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
498
引用
收藏
页数：3
相关论文
共 50 条
  • [21] THE IMPACT OF EDUCATION ON ADHERENCE TO TREATMENT WITH DISEASE MODIFYING ANTI-RHEUMATIC DRUGS IN RHEUMATOID ARTHRITIS PATIENTS
    Holc, I.
    Pahor, A.
    Gradisnik, S.
    Dai, K.
    Krajnc, M. Koren
    Grobelsek, V. Kovacic
    Dobnik, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 706 - 707
  • [22] Medication adherence in rheumatoid arthritis patients treated with biological disease-modifying anti rheumatic drugs
    Joensuu, J. T.
    Aaltonen, K. J.
    Valleala, H.
    Puolakka, K.
    Yli-Kerttula, T.
    Varjolahti-Lehtinen, T.
    Sokka, T.
    Blom, M.
    Nordstrom, D.
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2016, 45 (05) : 434 - 434
  • [23] Vaccinations in adults with rheumatoid arthritis in an era of new disease-modifying anti-rheumatic drugs
    Meroni, P. L.
    Zavaglia, D.
    Girmenia, C.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2018, 36 (02) : 317 - 328
  • [24] Integrating Nanotechnological Advancements of Disease-Modifying Anti-Rheumatic Drugs into Rheumatoid Arthritis Management
    Singh, Sukhbir
    Tiwary, Neha
    Sharma, Neelam
    Behl, Tapan
    Antil, Anita
    Anwer, Md. Khalid
    Ramniwas, Seema
    Sachdeva, Monika
    Elossaily, Gehan M.
    Gulati, Monica
    Ohja, Shreesh
    PHARMACEUTICALS, 2024, 17 (02)
  • [25] Cost-effective analysis of disease-modifying anti-rheumatic drugs in rheumatoid arthritis
    Syngle, Ashit
    Kaur, Sudeep
    Verma, Inderjeet
    Syngle, Tanya
    Syngle, Vijaita
    CLINICAL RHEUMATOLOGY, 2017, 36 (08) : 1715 - 1720
  • [26] Cost-effective analysis of disease-modifying anti-rheumatic drugs in rheumatoid arthritis
    Ashit Syngle
    Sudeep Kaur
    Inderjeet Verma
    Tanya Syngle
    Vijaita Syngle
    Clinical Rheumatology, 2017, 36 : 1715 - 1720
  • [27] The role of registries in the treatment of rheumatoid arthritis with biologic disease-modifying anti-rheumatic drugs
    Pombo-Suarez, Manuel
    Gomez-Reino, Juan
    PHARMACOLOGICAL RESEARCH, 2019, 148
  • [28] Can we discontinue synthetic disease-modifying anti-rheumatic drugs in rheumatoid arthritis?
    Scott, I. C.
    Kingsley, G. H.
    Scott, D. L.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2013, 31 (04) : S4 - S8
  • [29] The economic burden of switching targeted disease-modifying anti-rheumatic drugs among rheumatoid arthritis patients
    Shahabi, Ahva
    Shafrin, Jason
    Zhao, Lauren
    Green, Sarah
    Curtice, Tammy
    Marshall, Alexander
    Paul, Damemarie
    JOURNAL OF MEDICAL ECONOMICS, 2019, 22 (04) : 350 - 358
  • [30] Association between obesity and remission in rheumatoid arthritis patients treated with disease-modifying anti-rheumatic drugs
    Ahmad Y. Abuhelwa
    Ashley M. Hopkins
    Michael J. Sorich
    Susanna Proudman
    David J. R. Foster
    Michael D. Wiese
    Scientific Reports, 10
12345